Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-10 Sale | 2024-04-12 6:23 pm | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 67,000 | $23.36 | $1,564,812 | 146,903 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 8:40 pm | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 3,485 | $19.15 | $66,729 | 84,761 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 9:32 pm | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 3,237 | $19.08 | $61,758 | 104,674 (Direct) | View |
| 2024-03-20 Sale | 2024-03-22 7:46 pm | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 13,278 | $19.16 | $254,462 | 41,912 (Direct) | View |
| 2023-02-22 Sale | 2023-02-22 8:25 pm | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 32,861 | $4.66 | $153,132 | 87,835 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 6:24 pm | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 11,313 | $3.91 | $44,234 | 120,696 (Direct) | View |
| 2020-12-17 Sale | 2020-12-21 4:47 pm | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 4,999 | $25 | $124,975 | 263,999 (Direct) | View |
| 2020-12-14 Sale | 2020-12-16 4:15 pm | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 1 | $25 | $25 | 268,998 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-10 Exercise | 2024-04-12 6:23 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 62,420 | $12.6 | 146,903 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-12 6:23 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 4,580 | $19.68 | 146,903 (Direct) | View |
| 2024-04-10 Exercise | 2024-04-12 6:23 pm | N/A 2028-10-19 | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 67,000 | $0 | 146,903 (Direct) | View |
| 2024-04-04 Exercise | 2024-04-08 8:40 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 3,485 | $12.6 | 84,761 (Direct) | View |
| 2024-04-04 Exercise | 2024-04-08 8:40 pm | N/A 2028-10-19 | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 3,485 | $0 | 84,761 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 9:32 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 94 | $12.6 | 104,674 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 9:32 pm | N/A 2028-10-19 | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 3,237 | $0 | 104,674 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 9:32 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 3,143 | $5.52 | 104,674 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 7:46 pm | N/A 2032-01-27 | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 13,278 | $0 | 41,912 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 7:46 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 13,278 | $5.52 | 41,912 (Direct) | View |
| 2024-02-13 Option Award(A) | 2024-02-20 7:24 pm | N/A 2034-02-13 | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 23,364 | $0 | 23,364 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:41 pm | N/A 2034-02-12 | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 16,835 | $0 | 16,835 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-15 4:06 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director | 2,302 | $0 | 6,906 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:25 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director | 22,346 | $0 | 22,346 (Direct) | View |
| 2023-02-23 Option Award | 2023-04-06 8:15 pm | N/A 2033-02-23 | Enliven Therapeutics Inc. | ELVN | Ballal Rahul D. Director | 27,567 | $0 | 27,567 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:31 pm | N/A 2032-08-11 | AGIOS PHARMACEUTICALS INC. | AGIO | Ballal Rahul D. Director | 44,853 | $0 | 44,853 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 5:02 pm | N/A 2032-01-27 | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 131,400 | $0 | 268,409 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:44 pm | N/A 2031-01-27 | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 133,350 | $0 | 133,959 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-21 4:47 pm | N/A N/A | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 4,999 | $3.15 | 263,999 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-21 4:47 pm | N/A 2028-10-18 | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 4,999 | $0 | 263,999 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 4:15 pm | N/A N/A | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 1 | $3.15 | 268,998 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-16 4:15 pm | N/A 2028-10-18 | IMARA Inc. | IMRA | Ballal Rahul D. Chief Executive Officer | 1 | $0 | 268,998 (Direct) | View |
Ownership | 2020-03-11 6:23 pm | N/A 2028-10-18 | IMARA Inc. | IMRA | Ballal Rahul D. President & CEO | 0 | $0 | 690,433 (Direct) | View |